A prospective clinical trial of the second ‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer

ConclusionsTOS has the potential for both definitive resection and function preservation with minimal invasiveness. Identification of the risk factors for TOS is advantageous for accurate treatment selection in patients with early T ‐stage HNC.

Source: Cancer Medicine - October 7, 2019 Category: Cancer & Oncology Authors: Goshi Nishimura, Daisuke Sano, Yasuhiro Arai, Takashi Hatano, Hideaki Takahashi, Teruhiko Tanabe, Takashi Wada, Daiki Morishita, Nobuhiko Oridate Tags: ORIGINAL RESEARCH Source Type: research